Print page Close print preview
Logo Going International
Accedi a banche dati online | Convegnodetail
 

6th Obesity and NASH Drug Development Summit 2022

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 09:55 - 16:40
 
Temi della conferenza
The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1277295-3?pid=4832

Speakers: Allison Goldfine, Director, Translational Medicine Cardiometabolic Disease, Novartis, Andrew Billin, Senior Director Biomarker Sciences, Gilead, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1277295-2?pid=4832
Ms. Jessica Durston
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom